American Century Companies Inc Bridge Bio Pharma, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 926,846 shares of BBIO stock, worth $21.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

926,846

Previous 1,096,734 15.49%

Holding current value

$21.5 Million

Previous $27.8 Million 15.06%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$23.91 - $31.3 $4.06 Million - $5.32 Million	-169,888 Reduced 15.49%	926,846 $23.6 Million
Q2 2024 Aug 07, 2024	BUY	$23.0 - $31.04 $4.2 Million - $5.67 Million	182,623 Added 19.98%	1,096,734 $27.8 Million
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $12.1 Million - $17.9 Million	442,245 Added 93.72%	914,111 $28.3 Million
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $11.3 Million - $20.7 Million	471,866 New	471,866 $19 Million
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $5.02 Million - $10.4 Million	297,167 Added 2671.16%	308,292 $8.13 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $3,721 - $5,042	280 Added 2.58%	11,125 $191,000
Q1 2023 May 11, 2023	SELL	$7.17 - $18.55 $896 - $2,318	-125 Reduced 1.14%	10,845 $179,000
Q4 2022 Feb 13, 2023	SELL	$6.74 - $11.52 $2.19 Million - $3.75 Million	-325,456 Reduced 96.74%	10,970 $83,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $24,280 - $37,796	3,058 Added 0.92%	336,426 $3.34 Million
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $16,484 - $38,410	-3,164 Reduced 0.94%	333,368 $3.03 Million
Q1 2022 May 11, 2022	BUY	$7.34 - $17.16 $957,613 - $2.24 Million	130,465 Added 63.31%	336,532 $3.42 Million
Q4 2021 Feb 07, 2022	SELL	$11.38 - $53.41 $607,111 - $2.85 Million	-53,349 Reduced 20.57%	206,067 $3.44 Million
Q3 2021 Nov 10, 2021	SELL	$46.87 - $64.24 $19,122 - $26,209	-408 Reduced 0.16%	259,416 $12.2 Million
Q2 2021 Aug 05, 2021	BUY	$46.47 - $63.93 $512,378 - $704,892	11,026 Added 4.43%	259,824 $15.8 Million
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $225,596 - $294,247	-4,067 Reduced 1.61%	248,798 $15.3 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $1.15 Million - $2.13 Million	29,898 Added 13.41%	252,865 $18 Million
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $726,947 - $1.13 Million	26,726 Added 13.62%	222,967 $8.37 Million
Q2 2020 Aug 13, 2020	BUY	$22.22 - $35.69 $4.36 Million - $7 Million	196,241 New	196,241 $6.4 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Bridge Bio Pharma, Inc. Transaction History